We are live on
!
Find out more
BRCM
Bright Rock Capital Management Portfolio holdings
AUM
$499M
1-Year Est. Return
8.36%
This Fund
S&P 500
This Quarter
Est. Return
+1.68%
1 Year Est. Return
+8.36%
3 Year Est. Return
+41.76%
5 Year Est. Return
+64.28%
10 Year Est. Return
+252.44%
AUM
$509M
AUM Growth
-$1.51M
(-0.3%)
Cap. Flow
-$3.63M
Cap. Flow
% of AUM
-0.71%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
78
New
5
Increased
2
Reduced
7
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$7.69M |
| 2 |
NVIDIA
NVDA
|
+$7.45M |
| 3 |
Elevance Health
ELV
|
+$7.1M |
| 4 |
Zoetis
ZTS
|
+$7.04M |
| 5 |
Morgan Stanley
MS
|
+$2.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$9.57M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$7.14M |
| 3 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$6.69M |
| 4 |
SLB Ltd
SLB
|
+$5.44M |
| 5 |
Copart
CPRT
|
+$3.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.96% |
| 2 | Financials | 15.84% |
| 3 | Healthcare | 13.68% |
| 4 | Communication Services | 9.24% |
| 5 | Consumer Discretionary | 8.87% |
Similar funds
HCI
KCL
PPC
AGP
MIP
H2CM
HIC
SWM
Bright Rock Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Bright Rock Capital Management held 78 positions worth $509M, down 0.3% from $510M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bright Rock Capital Management's Q4 2025 filing shows 5 new, 2 increased, 7 reduced and 1 closed positions. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 50,000 shares worth $7.76M. The largest sale was West Pharmaceutical, an estimated $9.57M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Bright Rock Capital Management's largest Q4 2025 buy was State Street Industrial Select Sector SPDR ETF: 50,000 shares worth $7.76M.
- Bright Rock Capital Management added most to Accenture in Q4 2025, an estimated $1.78M increase.
- Bright Rock Capital Management's biggest Q4 2025 reduction was West Pharmaceutical, cutting an estimated $9.57M.
- Bright Rock Capital Management fully exited Fidelity MSCI Health Care Index ETF in Q4 2025, selling an estimated $6.69M.
- Bright Rock Capital Management's ten largest holdings make up 36% of its $509M portfolio in Q4 2025.
- Bright Rock Capital Management opened 5 new positions and closed 1 in Q4 2025.
- Bright Rock Capital Management's portfolio value fell 0.3% quarter-over-quarter to $509M.
Based on Bright Rock Capital Management's 13F filing for Q4 2025, filed 15 Jan 2026.